Journey Medical Corporation
DERMDrugs in Pipeline
6
Phase 3 Programs
3
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How DERM's past catalysts played out
Glycopyrronium Topical Wipes
Hyperhidrosis
DFD-29
Papulopustular Rosacea
Doxycycline
Papulopustular Rosacea
Dose 1 of glycopyrrolate, 2.0% QD
Hyperhidrosis
glycopyrrolate, 1.0%
Hyperhidrosis
Glycopyrronium cloth, 2.4%
Palmar Hyperhidrosis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Glycopyrronium Topical Wipes | Phase 3 | Hyperhidrosis | - | - |
DFD-29 | Phase 3 | Papulopustular Rosacea | - | - |
Doxycycline | Phase 3 | Papulopustular Rosacea | - | - |
Dose 1 of glycopyrrolate, 2.0% QD | Phase 2 | Hyperhidrosis | - | - |
glycopyrrolate, 1.0% | Phase 2 | Hyperhidrosis | - | - |
Glycopyrronium cloth, 2.4% | Phase 2 | Palmar Hyperhidrosis | - | - |
Hyperhidrosis
3 drugs in this indication
Palmar Hyperhidrosis
1 drug in this indication
Papulopustular Rosacea
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Journey Medical Corporation's drug pipeline?→
CatalystAlert tracks 6 drug candidates in Journey Medical Corporation's (DERM) pipeline across Phase 3, Phase 2. Its lead program is Glycopyrronium Topical Wipes (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Journey Medical Corporation's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Journey Medical Corporation (DERM) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track DERM biotech catalysts?→
Add DERM to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Journey Medical Corporation's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.